Additionally, our inability to test for Glutamic Acid Decarboxylase Autoantibody type 65 (GAD 65) especially in T2DM subjects in the early forties meant we may have enrolled patients with Latent Autoimmune Diabetes of Adults in the study. This evidence concerns the gene GAD2 and type 2 diabetes mellitus.